28 results
8-K
EX-99.1
LBPH
Longboard Pharmaceuticals, Inc.
1 Jul 24
Regulation FD Disclosure
9:15am
designation is eligible for more intensive guidance on an efficient drug development program and organizational commitment involving senior managers from
PRE 14A
hajrmzw 8trgm3s
28 Mar 24
Preliminary proxy
4:36pm
8-K
EX-3.1
3rjo01la r07
22 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:21pm
8-K
EX-99.1
mc1uox
23 Aug 23
Enrolled 52 participants with Developmental and Epileptic Encephalopathies (DEEs) into the PACIFIC Study
8:46am
DEF 14A
fgt1 kbrxbj4w6kdh365
13 Apr 22
Definitive proxy
4:15pm
10-K
2h10 z9zqpfh
3 Mar 22
Annual report
4:31pm
10-Q
EX-3.2
3zthk
10 May 21
Quarterly report
4:45pm
424B4
bwd8ocgmj hbi8
12 Mar 21
Prospectus supplement with pricing info
5:02pm
S-1/A
ug4dp0vfraemi1uqgw01
8 Mar 21
IPO registration (amended)
6:13am
S-1/A
EX-3.1
ypd1l88zwk9zke5t
8 Mar 21
IPO registration (amended)
6:13am
S-1/A
EX-10.4
3qxo43m5l
8 Mar 21
IPO registration (amended)
6:13am